Vitiligo

Vitiligo is a chronic, acquired autoimmune condition characterized by the progressive loss of functional melanocytes from the epidermis, resulting in well-demarcated depigmented patches of skin. It is non-contagious and can manifest at any age, though it most frequently presents before the age of
30.

The etiology is multifactorial, involving a complex interplay between genetic predisposition, autoimmune mechanisms, and environmental triggers. Oxidative stress is hypothesized to induce melanocyte apoptosis, triggering an immune response.

Vitiligo involves the destruction of melanocytes. Current models suggest a "convergent theory" where metabolic stress leads to the release of reactive oxygen species (ROS). This triggers an innate immune response, followed by adaptive CD8+ T-cell-mediated destruction of melanocytes, resulting in a total absence of melanin in the affected skin.

Vitiligo affects approximately 0.5% to 2% of the global population. It occurs across all ethnicities and genders equally, though it is more aesthetically apparent in individuals with darker skin tones.

• Family history of vitiligo or autoimmune disorders.
• Presence of other autoimmune diseases (e.g., thyroiditis).
• Chronic oxidative stress.
• Physical trauma or chemical exposure (Koebner phenomenon).

A. Early Symptoms

• Small areas of hypopigmentation (milky white spots).


• Premature graying of scalp hair or eyelashes. B. Common Symptoms


• Macules or patches of depigmentation, often on sun-exposed areas.


• Symmetrical distribution (Vitiligo vulgaris). C. Advanced Symptoms


• Extensive body surface area involvement (Generalized vitiligo).


• Involvement of mucosal membranes. D. Emergency Symptoms


• None; vitiligo is not life-threatening.

Inspection reveals depigmented, stark-white macules with well-defined borders. Patches may appear with trichrome or confetti-like patterns. Palpation usually reveals normal skin texture.

A. Clinical Assessment: History and physical examination.
B. Laboratory Testing: Thyroid function tests (TSH, T4), ANA panel.
C. Imaging Studies: Wood’s lamp examination.
D. Functional Tests: Not applicable.
E. Biopsy Findings: Absence of melanocytes on H&E and Melan-A staining.
F. Genetic Testing: Not routinely performed.
G. Differential Diagnosis: Pityriasis alba, tinea versicolor, chemical leukoderma.

Thyroid Stimulating Hormone (TSH)
Type: Blood Test
Purpose: Screen for associated autoimmune thyroid disease.
Expected Findings: Often normal; abnormal in comorbid cases.
Interpretation: Elevated/low TSH indicates autoimmune thyroiditis.

Wood’s Lamp Examination: Uses UV light (365 nm) to highlight depigmented areas. Provides high contrast between normal and affected skin; essential for clinical diagnosis.

• Pityriasis alba: Characterized by scaling, less distinct margins.
• Tinea versicolor: Fungal infection, presence of scale.
• Chemical leukoderma: History of industrial chemical exposure.

• Increased risk of sunburn and skin cancer.
• Psychological distress (depression/anxiety).
• Ocular and auditory abnormalities.

A. Lifestyle Modifications: Use of high-SPF sunscreen, sun avoidance.
B. Preventive Measures: Avoidance of known skin irritants.
C. Medical Treatment:

• Topical Corticosteroids: Suppress immune activity.


• Calcineurin Inhibitors (Tacrolimus/Pimecrolimus): Immunomodulation.


• Phototherapy: NB-UVB (Narrowband Ultraviolet B) light therapy.

Chronic and unpredictable. Repigmentation is possible but often incomplete. Stability is the primary goal of treatment.

No primary prevention exists. Secondary prevention focuses on early phototherapy intervention to stabilize progression.

The following homeopathic remedies have been historically indicated for symptoms associated with Vitiligo. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Vitiligo.